Thompson Jeffery S's Form 4 filing
Anika Therapeutics, Inc. (ANIK) · filed Mar 15, 2022
- Accession no.
- 0001171843-22-001878
- Filed
- Mar 15, 2022
- Trade date
- Mar 11, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $49.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thompson Jeffery SCIK 0001510398 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2022 | Common Stock | PPurchaseAcquired | +2,000 | $24.66F1 | +$49,320 | 17,121 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
On March 11, 2022, Mr. Thompson purchased 2,000 shares in multiple trades ranging from $24.53 to $24.70. The price reported above reflects the weighted average purchase price. Mr. Thompson undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.